SABCS 2023 | AI in routine clinical practice for breast cancer: next steps?

Fresia Pareja, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, gives her thoughts on the use of artificial intelligence (AI) in the diagnosis of patients, inform clinical trials, and on how the integration of AI with genomics is very robust. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.